Good news | Shanghai medicine was awarded "national hi-tech enterprise" certification

　　Recently, the Shanghai Municipal Science and Technology Commission, Shanghai Municipal Bureau of Finance and Shanghai Municipal Tax Bureau of the State Administration of Taxation jointly recognized that Shanghai Pharma was awarded the "High-tech Enterprise Certificate" of Shanghai.

Shanghai Pharma won the "High-tech Enterprise Certificate"

　　New and high-tech enterprises refer to knowledge-intensive and technology-intensive economic entities that continuously conduct research and development and transform technological achievements in Key State-supported New and high-tech Fields, form core independent intellectual property rights of enterprises, and carry out business activities based on them.

　　Since its establishment, Shanghai Pharma has been committed to supporting the international and domestic research and development of innovative drugs, helping innovative traditional pharmaceutical enterprises and biotechnology enterprises to promote the development and marketing of innovative drugs as soon as possible, providing them with the development of innovative drug apis and preparations, clinical samples and commercial batch product production services (CDMO). However, the production of clinical samples and commercial batches of products is based on the research and development of the production process of apis and preparations in the early stage, which is pilot-scale production and large-scale production. Therefore, research and innovation is always the core work, and the research and development team construction and intellectual property layout are carried out around the research and development of innovative drugs. Up to now, the company has obtained 15 intellectual property rights, including 2 utility model patents and 13 software Copyrights. In the first half of 2021, the company has increased research and development investment and technical protection measures, and has successfully applied for 9 invention patents for the core technology of drug development.

　　Shanghai Pharma was recognized as a "National high-tech Enterprise", which represents the government's high recognition of the R&D work of Shanghai Pharma, and reflects the core competitiveness and innovation advantages of Shanghai Pharma. At the same time, this is also an incentive for our company. We will take this as the driving force, adhere to research and development and innovation, stable production and supply, improve technical services, further enhance brand awareness, and help the steady development of the pharmaceutical market.

　　In the future, Sinodrug will shoulder the honor and responsibility, develop steadily, and strive to become the leading CDMO service platform in China.